Skip to main content
SpringerLink
Log in

A case of PRES in an active lupus nephritis patient after treatment of corticosteroid and cyclophosphamide

  • Letter to the Editor - Cases with a Message
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Posterior reversible encephalopathy syndrome (PRES) is primarily a radiological diagnosis. The syndrome is characterized by headache, altered mental status, seizures, and bilateral posterior white matter edema in a nonvascular distribution on neuroimaging with resolution of findings usually in 7–14 days (Casey et al. in AJNR Am J Neuroradiol 21:1199–1206, 2000). In most cases, computed tomography of the brain will show hypodense lesions in the parieto-occipital lobe. Although this syndrome is uncommon, prompt and accurate recognition allows early treatment, which has been shown to produce favorable outcomes. It is hypothesized that the dysfunction can be caused by a failure of autoregulation systemic hypertension or by the cytotoxic effects of vasculitides and immunosuppressive drugs. The present report is a possible second case of cyclophosphamide-induced PRES in a 16-year-old girl with systemic lupus erythematous and lupus nephritis. The initial suspected diagnosis was an ischemic stroke, but it was later changed, with resolution of symptoms after management of the underlying cause.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Casey SO, Sampaio RC, Michel E, Truwit CL (2000) Posterior reversible encephalopathy syndrome: utility of fluidattenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 21:1199–1206

    CAS  PubMed  Google Scholar 

  2. Hinchey J, Chaves C, Appignani B et al (1996) A reversible posterior leucoencephalopathy syndrome. N Engl J Med 334:494–500

    Article  CAS  PubMed  Google Scholar 

  3. Casey SO, Sampaio RC, Michel E, Truwit CL (2000) Posterior reversible encephalopathy syndrome: utility of fl uid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 21(7):1199–1206

    CAS  PubMed  Google Scholar 

  4. Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA (2010) Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 85(5):427–432

    Article  PubMed Central  PubMed  Google Scholar 

  5. Ni J, Zhou LX, Hao HL et al (2011) The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: a retrospective series of 24 patients. J Neuroimaging 21:219–224

    Article  PubMed  Google Scholar 

  6. Varaprasad IR, Agrawal S, Prabu VN, Rajasekhar L, Kanikannan MA, Narsimulu G (2011) Posterior reversible encephalopathy syndrome in systemic lupus erythematosus. J Rheumatol 38:1607–1611

    Article  PubMed  Google Scholar 

  7. Kur JK, Esdaile JM (2006) Posterior reversible encephalopathy syndrome—an underrecognized manifestation of systemic lupus erythematosus. J Rheumatol 33(11):2178–2183

    PubMed  Google Scholar 

  8. Ishimori ML, Pressman BD, Wallace DJ, Weisman MH (2007) Posterior reversible encephalopathy syndrome: another manifestation of CNS SLE? Lupus 16(6):436–443

    Article  CAS  PubMed  Google Scholar 

  9. Gasparovic C, Qualls C, Greene ER, Sibbitt WL, Roldan CA (2012) Blood pressure and vascular dysfunction underlie elevated cerebral blood flow in systemic lupus erythematosus. Rheumatology 39(4):752–758

    Article  Google Scholar 

  10. Matsui A, Ikeuchi H, Shimizu A et al (2012) Posterior reversible encephalopathy syndrome and scleroderma renal crisis developed in a patient with overlap syndrome after treatment with high-dose steroids and tacrolimus. Nihon Naika Gakkai Zasshi 101(7):2051–2054

    Article  PubMed  Google Scholar 

  11. Ishikura K, Ikeda M, Hamasaki Y et al (2006) Posterior reversible encephalopathy syndrome in children: its high prevalence and more extensive imaging findings. Am J Kidney Dis 48:231–238

    Article  PubMed  Google Scholar 

  12. Cellucci T, Benseler SM (2011) Posterior reversible encephalopathy syndrome: increasing recognition of an important clinical entity in young patients with systemic lupus erythematosus. J Rheumatol 38:1544–1545

    Article  PubMed  Google Scholar 

  13. Abenza-Abildua MJ et al (2009) Cyclophosphamide-induced reversible posterior leukoencephalopathy syndrome. BMJ Case Rep. doi:10.1136/bcr.07.2008.0467

  14. Zhang Y, Liu J, Ding M et al (2008) Reversible posterior encephalopathy syndrome in systemic lupus erythematosus and lupus nephritis. Intern Med 47:867–875

    Article  PubMed  Google Scholar 

  15. Kadikoy Huseyin et al (2012) Posterior reversible encephalopathy syndrome in a patient with lupus nephritis. Saudi J Kidney Dis Transpl 23(3):572–576

    PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Nephrology and Kidney Transplantation, Medical University Hospital, University Caddi Ayad, Marrakech, Morocco

    M. Jabrane, Z. Ait Lahcen, W. Fadili & I. Laouad

Authors
  1. M. Jabrane
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Z. Ait Lahcen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. Fadili
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. Laouad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Jabrane.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jabrane, M., Lahcen, Z.A., Fadili, W. et al. A case of PRES in an active lupus nephritis patient after treatment of corticosteroid and cyclophosphamide. Rheumatol Int 35, 935–938 (2015). https://doi.org/10.1007/s00296-014-3173-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-014-3173-1

Keywords

Search

Navigation